Physician

Aaron Fearday, M.D.

According to 2025 Medicare claims, Aaron Fearday, M.D. (NPI: 1952543118) practices nephrology in the Boise City, ID market, with the plurality of this provider's patient population coming from Ada, ID. This provider's primary affiliated billing organization is ST LUKES CLINIC-TREASURE VALLEY LLC (NPI: 1326336058; TIN: 452716222) and primary practice location at 83702-6971. Fearday is affiliated with the St. Luke's Clinic Coordinated Care, Ltd (ACO ID: D0059), participating under the REACH model.

Fearday's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 323 traditional Medicare patients, billed 652 HCPCS/CPT codes, and received $63,144 in Medicare payments. The top billing code was 90962 (Dialysis services, 1 physician visit per month (20 years or older)). Part D data shows 1,920 prescription claims across 403 beneficiaries totaling $510,035 in drug costs, led by Farxiga (Dapagliflozin Propanediol). DME data shows 64 claims. Open Payments data shows 6 records totaling $17. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $27,971 to $510,035. In contrast, DME billing represents a smaller volume and changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	399	1,347	$92,989
2016	366	1,290	$94,347
2017	430	1,374	$107,629
2018	469	1,616	$124,697
2019	494	1,590	$142,267
2020	448	1,459	$140,028
2021	412	1,055	$99,668
2022	372	984	$92,022
2023	323	791	$83,503
2024	323	652	$63,144

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	186	811	$27,971
2016	235	1,247	$96,234
2017	336	1,769	$145,836
2018	416	2,458	$135,042
2019	445	3,065	$204,012
2020	420	2,984	$308,854
2021	475	2,886	$323,618
2022	483	3,092	$482,442
2023	450	2,520	$630,484
2024	403	1,920	$510,035

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	12	$566
2016	N/R	23	$701
2017	N/R	109	$2,709
2018	N/R	122	$4,002
2019	N/R	82	$2,899
2020	N/R	87	$3,735
2021	N/R	67	$2,514
2022	N/R	93	$1,966
2023	N/R	45	$551
2024	N/R	64	$630

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90962	Dialysis services, 1 physician visit per month (20 years or older)	17	46	$142
99222	Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes	30	33	$88
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	75	75	$84
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	155	196	$60
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	45	110	$56

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	160	10,483	$190,970
Jardiance	Empagliflozin	53	3,665	$72,981
Renvela	Sevelamer Carbonate	15	1,050	$53,498
Ozempic	Semaglutide	29	1,238	$37,084
Lokelma	Sodium Zirconium Cyclosilicate	25	1,446	$29,892

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	20	$358
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	16	$201
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	11	$58
J7512	Prednisone, immediate release or delayed release, oral, 1 mg	N	N/R	17	$13

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	6	$17	Travere Therapeutics, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Aaron Fearday, M.D.?

Tedicare shows public-source Medicare data for Aaron Fearday, M.D. (NPI 1952543118), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Aaron Fearday, M.D. have ACO affiliation data?

Aaron Fearday, M.D. is shown with ACO affiliation data for St. Luke's Clinic Coordinated Care, Ltd (REACH, ACO ID D0059).

What billing organization is linked to Aaron Fearday, M.D.?

Aaron Fearday, M.D. is linked to ST LUKES CLINIC-TREASURE VALLEY LLC (billing NPI 1326336058) in the available physician profile data.

Does Aaron Fearday, M.D. have Open Payments data?

Aaron Fearday, M.D. has 6 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.